JPMorgan Chase & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-108,407
| Closed | -$6.37M | – | 6833 |
|
|
2023
Q4 | $6.37M | Buy |
108,407
+38,528
| +55% | +$2.26M | ﹤0.01% | 2409 |
|
|
2023
Q3 | $3.04M | Buy |
69,879
+30,805
| +79% | +$1.34M | ﹤0.01% | 2735 |
|
|
2023
Q2 | $1.41M | Sell |
39,074
-20,774
| -35% | -$751K | ﹤0.01% | 3227 |
|
|
2023
Q1 | $2.23M | Buy |
59,848
+16,842
| +39% | +$626K | ﹤0.01% | 2982 |
|
|
2022
Q4 | $1.95M | Sell |
43,006
-116,870
| -73% | -$5.3M | ﹤0.01% | 2977 |
|
|
2022
Q3 | $11.2M | Buy |
159,876
+105,147
| +192% | +$7.34M | ﹤0.01% | 1797 |
|
|
2022
Q2 | $3.67M | Buy |
54,729
+26,463
| +94% | +$1.78M | ﹤0.01% | 2606 |
|
|
2022
Q1 | $2.32M | Buy |
28,266
+2,164
| +8% | +$178K | ﹤0.01% | 3072 |
|
|
2021
Q4 | $3.83M | Buy |
26,102
+3,259
| +14% | +$478K | ﹤0.01% | 2756 |
|
|
2021
Q3 | $4.04M | Sell |
22,843
-2,747
| -11% | -$486K | ﹤0.01% | 2721 |
|
|
2021
Q2 | $4.13M | Sell |
25,590
-305,484
| -92% | -$49.4M | ﹤0.01% | 2775 |
|
|
2021
Q1 | $56.7M | Sell |
331,074
-28,315
| -8% | -$4.85M | 0.01% | 1022 |
|
|
2020
Q4 | $78.9M | Buy |
359,389
+84,745
| +31% | +$18.6M | 0.01% | 800 |
|
|
2020
Q3 | $45.6M | Buy |
274,644
+258,420
| +1,593% | +$42.9M | 0.01% | 932 |
|
|
2020
Q2 | $1.85M | Buy |
16,224
+5,522
| +52% | +$630K | ﹤0.01% | 2716 |
|
|
2020
Q1 | $824K | Sell |
10,702
-6,510
| -38% | -$501K | ﹤0.01% | 3056 |
|
|
2019
Q4 | $2.22M | Buy |
17,212
+6,931
| +67% | +$893K | ﹤0.01% | 2641 |
|
|
2019
Q3 | $801K | Buy |
10,281
+1,951
| +23% | +$152K | ﹤0.01% | 3160 |
|
|
2019
Q2 | $871K | Buy |
8,330
+449
| +6% | +$46.9K | ﹤0.01% | 3124 |
|
|
2019
Q1 | $577K | Buy |
7,881
+2,729
| +53% | +$200K | ﹤0.01% | 3312 |
|
|
2018
Q4 | $219K | Buy |
5,152
+480
| +10% | +$20.4K | ﹤0.01% | 3771 |
|
|
2018
Q3 | $220K | Buy |
4,672
+994
| +27% | +$46.8K | ﹤0.01% | 3840 |
|
|
2018
Q2 | $181K | Buy |
+3,678
| New | +$181K | ﹤0.01% | 3859 |
|
|
2017
Q4 | – | Sell |
-2,777
| Closed | -$32K | – | 4753 |
|
|
2017
Q3 | $32K | Buy |
+2,777
| New | +$32K | ﹤0.01% | 3890 |
|
|
2017
Q2 | – | Sell |
-37,366
| Closed | -$194K | – | 4562 |
|
|
2017
Q1 | $194K | Sell |
37,366
-16,895
| -31% | -$87.7K | ﹤0.01% | 3495 |
|
|
2016
Q4 | $258K | Buy |
54,261
+24,201
| +81% | +$115K | ﹤0.01% | 3558 |
|
|
2016
Q3 | $199K | Sell |
30,060
-26,350
| -47% | -$174K | ﹤0.01% | 3260 |
|
|
2016
Q2 | $308K | Sell |
56,410
-20,750
| -27% | -$113K | ﹤0.01% | 3118 |
|
|
2016
Q1 | $1.65M | Buy |
77,160
+4,135
| +6% | +$88.5K | ﹤0.01% | 2453 |
|
|
2015
Q4 | $2.31M | Sell |
73,025
-8,500
| -10% | -$269K | ﹤0.01% | 2312 |
|
|
2015
Q3 | $2.81M | Buy |
81,525
+2,125
| +3% | +$73.1K | ﹤0.01% | 2232 |
|
|
2015
Q2 | $2.5M | Sell |
79,400
-5,925
| -7% | -$186K | ﹤0.01% | 2408 |
|
|
2015
Q1 | $2.5M | Sell |
85,325
-3,475
| -4% | -$102K | ﹤0.01% | 2439 |
|
|
2014
Q4 | $1.65M | Sell |
88,800
-4,325
| -5% | -$80.1K | ﹤0.01% | 2575 |
|
|
2014
Q3 | $1.63M | Buy |
+93,125
| New | +$1.63M | ﹤0.01% | 2536 |
|